Pulmatrix, Inc. - Common Stock (PULM)
7.0500
-0.7400 (-9.50%)
Pulmatrix Inc is a clinical-stage biopharmaceutical company focused on developing innovative therapies for respiratory diseases
The company utilizes its proprietary technology platform to create new treatments that target and modulate the underlying mechanisms of respiratory conditions, including chronic obstructive pulmonary disease (COPD) and asthma. Pulmatrix aims to improve the lives of patients through the development of novel inhaled therapeutics that enhance drug delivery and optimize treatment outcomes. With a commitment to advancing respiratory health, Pulmatrix is dedicated to bringing transformative solutions from the laboratory to the patients who need them.
Frequently Asked Questions
Is Pulmatrix, Inc. - Common Stock publicly traded?
Yes, Pulmatrix, Inc. - Common Stock is publicly traded.
What exchange does Pulmatrix, Inc. - Common Stock trade on?
Pulmatrix, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Pulmatrix, Inc. - Common Stock?
The ticker symbol for Pulmatrix, Inc. - Common Stock is PULM on the Nasdaq Stock Market
What is the current price of Pulmatrix, Inc. - Common Stock?
The current price of Pulmatrix, Inc. - Common Stock is 7.050
When was Pulmatrix, Inc. - Common Stock last traded?
The last trade of Pulmatrix, Inc. - Common Stock was at 3:33 pm EST on March 4th, 2025
What is the market capitalization of Pulmatrix, Inc. - Common Stock?
The market capitalization of Pulmatrix, Inc. - Common Stock is 25.75M
How many shares of Pulmatrix, Inc. - Common Stock are outstanding?
Pulmatrix, Inc. - Common Stock has 3.65M shares outstanding.